Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Apixaban in Peritoneal Dialysis (ApiDP)
NCT04006093Phase 1Completed
- Sponsor
- CHU Caen Normandie
- Start
- Dec 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of apixaban in thrombosis (2 arms), sponsored by CHU Caen Normandie. Primary endpoints: Apixaban Area Under the Curve at Day 3 and Apixaban Maximum Plasma Concentration at Day 3. Started Dec 2019; status: completed.
02
Drugs
apixaban
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT04006093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04006093.